Á¦ V ºÎ È£Èí±â°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the Respiratory
System) 325
Á¦36Àå Ç×È÷½ºÅ¸¹ÎÁ¦¿Í ÃæÇ÷ Á¦°ÅÁ¦(Antihistamines and Decongestants)
325
Á¦37Àå ±â°üÁöÈ®ÀåÁ¦ ¹× õ½Ä Ä¡·áÁ¦(Bronchodilators and Antiasthma
Drugs) 333
Á¦38Àå ÁøÇØÁ¦, Á¡¾×¿ëÇØÁ¦ ¹× °Å´ãÁ¦(Antitussives, Mucolytics, and
Expectorants) 350
Á¦ VI ºÎ ½ÉÇ÷°ü°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the
Cardiovascular System) 357
Á¦39Àå °½ÉÁ¦ ¹× ±âŸ ½É±Ù¼öÃà·Â Áõ°Á¦(Cardiotonics and
Miscellaneous Inotropic Drugs) 357
Á¦40Àå ºÎÁ¤¸Æ Ä¡·áÁ¦(Antiarrhythmic Drugs) 367
Á¦41Àå Çù½ÉÁõ Ä¡·áÁ¦ ¹× ¸»ÃÊÇ÷°ü È®ÀåÁ¦(Antianginal and Peripheral
Vasodilating Drugs) 380
Á¦42Àå °íÇ÷¾Ð Ä¡·áÁ¦(Antihypertensive Drugs) 393
Á¦43Àå °íÁöÁúÇ÷Áõ Ä¡·áÁ¦(Antihyperlipidemic Drugs) 407
Á¦ VII ºÎ Ç÷¾×°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the Hematological
System) 417
Á¦44Àå Ç×ÀÀ°íÁ¦¿Í Ç÷Àü¿ëÇØÁ¦(Anticoagulant and Thrombolytic Drugs) 417
Á¦45Àå ºóÇ÷Ä¡·á¿¡ »ç¿ëÇÏ´Â ¾à¹°(Agents Used in the Treatment of
Anemia) 433
Á¦ VIII ºÎ ¼Òȱâ°è ¹× ºñ´¢±â°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the
Gastrointestinal and Urinary Systems) 443
Á¦46Àå ÀÌ´¢Á¦(Diuretics) 443
Á¦47Àå ¿ä·Î°¨¿° Ä¡·áÁ¦¿Í ±âŸ ºñ´¢±â°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Urinary Anti-
infectives and miscellaneous Urinary Drugs) 456
Á¦48Àå À§Àå°ü°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the
Gastrointestinal System) 466
Á¦ X ºÎ ¸é¿ª°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect the Immune System)
567
Á¦54Àå ¸é¿ªÁ¦Á¦(Immunologic Agents) 567
Á¦55Àå Ç×¾ÏÁ¦(Antineoplastic Drugs) 583
Á¦ XI ºÎ ±âŸ ½Åü±â°ü¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°(Drugs That Affect Other Body
Systems) 603
Á¦56Àå ÇǺÎÁúȯġ·á¿¡ »ç¿ëÇÏ´Â ±¹¼Ò¿ë ¾à¹°(Topical Drugs Used in the
Treatment of Skin Disorders) 603
Á¦57Àå ±Í ¹× ´«¿¡ »ç¿ëÇÏ´Â ¾à¹°(Otic and Ophthalmic Preparations) 616
Á¦58Àå ¼ö¾×°ú ÀüÇØÁú(Fluids and Electrolytes) 633
¾à¾î(Abbreviations) 647
¿ë¾î Çؼ³(Glossary) 651
ºÎ·Ï(appendix)
A: Med Watch 657
B: ÀÇ·á¿ë ¾àÃÊ ¹× õ¿¬¹°(Select Herbs and Natural products Used for
Medicinal Purposes) 659
C: USP Medication Errors Reporting Program 662
D: ¹ÌÅ͹ý°ú ¾à¿ë½Ä µµ·®ÇüÀÇ µî°¡Ä¡(Metric-Apothecary Equivalents and
Conversions) 664
E: üǥ¸éÀû °è»êµµÇ¥(Body Surface Area Nomograms) 667
F: Vaccine Adverse Event Reporting System 669
G: ¿¬½À¹®Á¦ ÇØ´ä(Answers to Review Questions and Medication Dosage
Problems) 671
H: º´ÇÕÁ¦Á¦ÀÇ ¿¹(Examples of Combination Drugs) 679